DalsnaFinance › IPOs › Axsome Therapeutics Inc › IPO

Axsome Therapeutics, Inc. IPO

Completed

Axsome Therapeutics, Inc. completed its initial public offering on NASDAQ on November 19, 2015, pricing at $9.00 a share.

Ticker	AXSM
Exchange	NASDAQ
Status	Completed
Listing date	November 19, 2015
Offering price	$9.00
Shares offered	5,666,667
Total raised	$51M

The offering

Axsome Therapeutics, Inc. sold 5,666,667 shares at $9.00 each on NASDAQ. Multiplied out, that is $51 million in gross proceeds, the figure before underwriting discounts and offering expenses, and it agrees with the $51 million total recorded for the deal.

Company coverage

Axsome Therapeutics, Inc. — quote, profile and latest news →

Other recent IPOs

Iambic Therapeutics, Inc. · October 13, 2026
Retension Pharmaceuticals, Inc. · October 8, 2026
Frazier Life Sciences Acquisition Corp. II · October 8, 2026
TRex Bio, Inc. · October 6, 2026
Pine Tree Acquisition Corp. · October 5, 2026
Accelevation Holdings Corp. · September 30, 2026
Southport Acquisition Corp. II · September 30, 2026
ROZE AI INC. · September 28, 2026

Source: SEC EDGAR filings for Axsome Therapeutics, Inc.. This page is general information, not investment advice.